How does boric acid affect rats?

How does boric acid affect rats? - briefly

Boric acid acts as a systemic toxin in rats, producing gastrointestinal irritation, renal failure, and mortality when administered at doses above the established LD₅₀. Sub‑lethal exposure can impair growth and disrupt metabolic pathways.

How does boric acid affect rats? - in detail

Boric acid (H₃BO₃) exerts toxic effects on laboratory rodents when administered orally, intraperitoneally, or via inhalation. Absorption occurs primarily through the gastrointestinal tract, with peak plasma concentrations reached within 30–60 minutes after dosing. The compound distributes to the liver, kidneys, brain, and reproductive organs, where it interferes with cellular metabolism.

Key physiological responses include:

  • Metabolic disruption: Boric acid inhibits several enzymes of the glycolytic pathway and impairs oxidative phosphorylation, leading to reduced ATP production.
  • Renal impairment: Elevated serum boron concentrations cause tubular necrosis and glomerular filtration decline, manifested by increased creatinine and urea levels.
  • Neurotoxicity: Neuronal calcium homeostasis is altered, resulting in tremors, ataxia, and, at high doses, seizures. Histopathology reveals demyelination and loss of Purkinje cells in the cerebellum.
  • Reproductive toxicity: Chronic exposure reduces sperm count, motility, and viability, while female rats exhibit disrupted estrous cycles and decreased ovarian follicle density.
  • Hematological changes: Dose‑dependent anemia and leukopenia are observed, reflecting bone‑marrow suppression.

Dose–response relationships are well documented. The acute oral LD₅₀ for adult rats ranges from 2.5 g kg⁻¹ to 3.0 g kg⁻¹. Sub‑lethal doses (50–200 mg kg⁻¹) produce reversible biochemical alterations, whereas chronic exposure to 5–10 mg kg⁻¹ per day for 90 days leads to persistent organ damage and reduced growth rates.

Mechanistically, boric acid acts as a Lewis acid, forming complexes with cis‑diols in nucleic acids and membrane phospholipids. These complexes destabilize DNA replication and compromise membrane integrity, amplifying cytotoxicity. Additionally, boron interferes with the activity of Na⁺/K⁺‑ATPase, contributing to electrolyte imbalance and cellular swelling.

Experimental protocols commonly employ:

  1. Single‑dose toxicity: Administration of a defined amount followed by observation for 14 days, with necropsy to assess organ lesions.
  2. Sub‑chronic studies: Repeated dosing over 28–90 days, measuring body weight, food intake, blood chemistry, and histopathology.
  3. Behavioral assays: Rotarod and open‑field tests to quantify motor deficits and anxiety‑related behavior.

Interpretation of results requires consideration of strain differences, age, and sex, as these variables influence susceptibility. Rats of the Sprague‑Dawley lineage generally display higher tolerance than Wistar rats, while juvenile animals are more vulnerable to neurotoxic effects.

In summary, boric acid produces dose‑dependent metabolic, renal, neurological, and reproductive toxicity in rats. Acute high‑dose exposure leads to rapid organ failure, whereas prolonged low‑dose intake results in subtle yet cumulative dysfunctions. Accurate assessment of these effects relies on standardized dosing regimens, comprehensive biochemical profiling, and detailed histopathological analysis.